• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mol Biol Rep . Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19

tetano

Editor, Senior Moderator
Mol Biol Rep


. 2024 May 22;51(1):665.
doi: 10.1007/s11033-024-09578-3. Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19

Muinah Adenike Fowora[SUP] 1 [/SUP], Adenike Aiyedogbon[SUP] 2 [/SUP], Ibilola Omolopo[SUP] 2 [/SUP], Ahmed Oluwasegun Tajudeen[SUP] 2 [/SUP], Faustina Onyeaghasiri[SUP] 3 [/SUP], Idowu Edu-Muyideen[SUP] 4 [/SUP], Abdul-Lateef Olatunde Olanlege[SUP] 5 [/SUP], Aminah Abioye[SUP] 6 [/SUP], Tajudeen Akanji Bamidele[SUP] 2 [/SUP], Toyosi Raheem[SUP] 2 [/SUP], Adesegun Adesesan[SUP] 4 [/SUP], Bamidele Iwalokun[SUP] 2 [/SUP], Babatunde Lawal Salako[SUP] 2 [/SUP]



Affiliations
Abstract

Background: Staphylococcus aureus (S. aureus) associated with COVID-19 has not been well documented. This cross-sectional study evaluated the association between nasal S. aureus carriage and COVID-19.
Methods and results: Nasopharyngeal samples were collected from 391 participants presenting for COVID-19 test in Lagos, Nigeria, and S. aureus was isolated from the samples. Antimicrobial susceptibility test was done by disc diffusion method. All S. aureus isolates were screened for the presence of mecA, panton-valentine leucocidin (PVL) and toxic shock syndrome toxin (TSST) virulence genes by polymerase chain reaction. Staphylococcal protein A (spa) typing was conducted for all the isolates. Participants with COVID-19 had double the prevalence of S. aureus (42.86%) compared to those who tested negative (20.54%). A significant association was seen between S. aureus nasal carriage and COVID-19 (p = 0.004). Antimicrobial sensitivity results showed resistance to oxacillin (100%), cefoxitin (53%), and vancomycin (98.7%). However, only 41% of the isolates harbored the mecA gene, with SCCmecV being the most common SCCmec type. There was no association between the carriage of virulence genes and COVID-19. A total of 23 Spa types were detected, with t13249 and t095 being the two most common spa types.
Conclusion: This study examined the association between nasal S. aureus carriage and SARS-COV-2 infection. Further research is required to fully explore the implications of S. aureus co-infection with COVID-19.

Keywords: S. aureus; COVID-19; Coinfection; SCCmec; Spa types.

 
Back
Top Bottom